Anchor Investment Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $4.09K | Hold |
|
|||||
|
2024
Q1 | $4.23K | Hold |
|
|||||
|
2023
Q4 | $4.24K | Hold |
|
|||||
|
2023
Q3 | $2.18K | Hold |
|
|||||
|
2023
Q2 | $3.18K | Hold |
|
|||||
|
2023
Q1 | $2.44K | Hold |
|
|||||
|
2022
Q4 | $3.15K | Hold |
|
|||||
|
2022
Q3 | $2.83K | Hold |
|
|||||
|
2022
Q2 | $2.64K | Hold |
|
|||||
|
2022
Q1 | $3.5K | Hold |
|
|||||
|
2021
Q4 | $3.24K | Hold |
|
|||||
|
2021
Q3 | $2.95K | Hold |
|
|||||
|
2021
Q2 | $2.56K | Hold |
|
|||||
|
2021
Q1 | $1.37K | Buy |
|